UBS AM’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,081
Closed -$127K 2707
2022
Q1
$127K Hold
1,081
﹤0.01% 2722
2021
Q4
$230K Hold
1,081
﹤0.01% 2739
2021
Q3
$356K Hold
1,081
﹤0.01% 2591
2021
Q2
$281K Sell
1,081
-176
-14% -$109K ﹤0.01% 2656
2021
Q1
$574K Buy
1,257
+147
+13% +$80.3K ﹤0.01% 2340
2020
Q4
$388K Hold
1,110
﹤0.01% 2367
2020
Q3
$425K Buy
1,110
+6
+0.5% +$2.37K ﹤0.01% 2203
2020
Q2
$494K Buy
+1,104
New +$453K ﹤0.01% 2134

Other funds holding CVM

UBS AM's CVM Position: Q2 2022 in Review

UBS AM sold out of CEL-SCI Corp (CVM) in Q2 2022, closing a stake of 1,081 shares — an estimated $127K sold.

UBS AM first reported a position in CVM in Q2 2020 and held it in 8 quarters. The position peaked at $574K in Q1 2021. 81 funds tracked by Wall St. Rank hold CVM as of Q2 2022.

  • UBS AM reported no remaining CEL-SCI Corp position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 1,081 CEL-SCI Corp shares in Q2 2022, an estimated $127K.
  • UBS AM first reported a position in CEL-SCI Corp in Q2 2020 and held it in 8 quarters.
  • UBS AM's CEL-SCI Corp position peaked at $574K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.